Nkarta Inc (NKTX)
6.52
-0.30
(-4.40%)
USD |
NASDAQ |
May 17, 16:00
6.52
0.00 (0.00%)
After-Hours: 20:00
Nkarta Total Assets (Quarterly): 576.94M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 576.94M |
| December 31, 2023 | 378.88M |
| September 30, 2023 | 405.86M |
| June 30, 2023 | 429.04M |
| March 31, 2023 | 458.17M |
| December 31, 2022 | 472.94M |
| September 30, 2022 | 503.80M |
| June 30, 2022 | 503.64M |
| March 31, 2022 | 306.30M |
| Date | Value |
|---|---|
| December 31, 2021 | 273.90M |
| September 30, 2021 | 292.46M |
| June 30, 2021 | 309.11M |
| March 31, 2021 | 325.69M |
| December 31, 2020 | 337.65M |
| September 30, 2020 | 352.30M |
| June 30, 2020 | 43.62M |
| March 31, 2020 | 41.12M |
| December 31, 2019 | 48.41M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
41.12M
Minimum
Mar 2020
576.94M
Maximum
Mar 2024
336.66M
Average
344.97M
Median
Total Assets (Quarterly) Benchmarks
| Cutera Inc | 311.99M |
| GT Biopharma Inc | 14.11M |
| Outlook Therapeutics Inc | 59.03M |
| IMAC Holdings Inc | 1.144M |
| Capricor Therapeutics Inc | 49.44M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 103.28M |
| Shareholders Equity (Quarterly) | 473.65M |